Novartis AG Loses India Cancer Drug Patent Case

India's top court dismissed Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics. Read the full story